An immunologist who has turned entrepreneur builds a one-man publishing business around a 30,000-item directory It is one of those small yet irksome inconveniences that dog immunologists and those working with biological reagents. No matter how generous one's funding or how proficient one's technicians, there are certain nettlesome tasks that threaten to halt one's research. What to do, for example, when an experiment requires a highly specific monoclonal antibody? If it can't be found in a ca
An immunologist who has turned entrepreneur builds a one-man publishing business around a 30,000-item directory |
Enter William Dean Linscott, formerly an immunologist at the medical school of the University of California, San Francisco. In 1980 he dropped out of the laboratory to become sole proprietor of Linscott's Directory of Immunological and Biological Reagents. It's a guide to 30,000 different products, ranging from monoclonal antibodies and hybridomas ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
Unlock rapid, high-yield protein production with the Expi293™ PRO Expression System—an optimized HEK293 transient platform delivering exceptional yields for diverse, challenging proteins with scalable, automation-ready workflows.
